Risk factors for hospital readmission in adult patients with heart failure with reduced ejection fraction: a systematic review

被引:6
作者
Schjodt, Inge [1 ]
Liljeroos, Maria [2 ,3 ]
Larsen, Palle [4 ]
Johnsen, Soren Paaske [5 ]
Stromberg, Anna [2 ,6 ]
Logstrup, Brian Bridal [1 ,7 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[2] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[3] Uppsala Univ, Ctr Clin Res Sormland, Eskilstuna, Sweden
[4] Univ Coll Lillebaelt, Hlth Sci Res Ctr, Odense, Denmark
[5] Aalborg Univ, Dept Clin Med, Danish Ctr Clin Hlth Serv Res, Aalborg, Denmark
[6] Linkoping Univ Hosp, Dept Cardiol, Linkoping, Sweden
[7] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
all-cause readmission; heart failure; heart failure readmission; rehospitalization; risk factors; ASSOCIATION TASK-FORCE; BETA-BLOCKER USE; SYSTOLIC BLOOD-PRESSURE; TERM CLINICAL-OUTCOMES; ADMISSION SERUM SODIUM; 30-DAY READMISSION; AMERICAN-COLLEGE; ANTICOAGULATION THERAPY; PROGNOSTIC-SIGNIFICANCE; PERFORMANCE-MEASURES;
D O I
10.11124/JBISRIR-D-19-00203
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective:The objective of this review was to identify and synthesize evidence on risk factors associated with hospital readmission within the first year after heart failure hospitalization among patients with heart failure with reduced left ventricular ejection fraction.Introduction:Heart failure is associated with a high risk of hospital readmission. Readmissions are associated with higher mortality and health care costs. It is a high health care priority to identify vulnerable patients with heart failure who may potentially benefit from targeted personalized care interventions aiming to reduce readmissions.Inclusion criteria:This review considered studies including adult patients who had heart failure with a reduced left ventricular ejection fraction <= 40% who were discharged after a heart failure hospitalization. The authors included studies with experimental and observational designs evaluating risk factors for i) all-cause hospital readmission, ii) heart failure hospital readmission, and iii) composite outcomes within seven, 15, 30, 60, 90, 180, and 365 days after hospital discharge. Composite outcomes included end points where all-cause readmission and/or heart failure readmission were part of a defined end point (i.e. all-cause readmission or mortality; heart failure readmission or mortality; cardiovascular readmission; cardiovascular readmission or mortality; and readmission, mortality, or cardiac transplant). Studies reporting all-cause readmission and/or heart failure readmission as a primary outcome, secondary outcome, or part of a composite outcome were included.Methods:PubMed, Embase, CINAHL, Cochrane CENTRAL, PsycINFO, OpenGrey, MedNar, DART-Europe, ProQuest Dissertations and Theses, and the Grey Literature Report in Public Health were searched to find both published and unpublished studies in English, Swedish, Norwegian, or Danish from 2000 to June 2018. Study selection, critical appraisal, data extraction, and data synthesis followed the JBI approach for systematic reviews. Statistical pooling was not possible due to clinical and methodological heterogeneity of the studies included and the lack of risk factors reported more than once. A narrative summary of the findings was performed.Results:Fifty-two studies, including one randomized controlled trial and 51 cohort studies with a total of 128,186 participants, were included. Risk factors for readmission were reported for 30-day outcome in 16 studies, 60-day in three studies, 90-day in 15 studies, 180-day in 12 studies, and 365-day outcome in 15 studies. Based on multivariable analyses from 43 cohort studies and results from one randomized controlled trial, the authors identified several factors associated with higher risk of all-cause readmission, heart failure readmission, and composite outcomes (e.g. readmission or death) within 30, 60, 90, 180, and 365 days after discharge for a heart failure hospitalization.Conclusions:This review provides a comprehensive overview of factors associated with a clinical outcome after a heart failure hospitalization in patients with heart failure with left ventricular ejection fraction <= 40%. Owing to the heterogeneity of variables investigated and the lack of comparability of findings, the clinical impact of the identified risk factors remains uncertain. This review highlights research gaps and the need for a standardized way to define and measure all-cause readmission, heart failure readmission, and composite end points in clinical research to improve study quality and enable comparison of findings between studies.
引用
收藏
页码:1641 / 1700
页数:60
相关论文
共 101 条
  • [71] Omar HR, 2018, HERZ, V43, P649, DOI 10.1007/s00059-017-4612-z
  • [72] Clinical and Prognostic Significance of Positive Hepatojugular Reflux on Discharge in Acute Heart Failure: Insights from the ESCAPE Trial
    Omar, Hesham R.
    Guglin, Maya
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [73] Ratio of Systolic Blood Pressure to Right Atrial Pressure, a Novel Marker to Predict Morbidity and Mortality in Acute Systolic Heart Failure
    Omar, Hesham R.
    Charnigo, Richard
    Guglin, Maya
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (07) : 1061 - 1068
  • [74] -Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens, Ryan E.
    Twilla, Jennifer D.
    Self, Timothy H.
    Alshaya, Abdulrahman I.
    Metra, Carlvin J.
    Cummings, Carolyn
    Oliphant, Carrie S.
    [J]. JOURNAL OF PHARMACY PRACTICE, 2018, 31 (01) : 40 - 45
  • [75] Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure
    Parissis, J. T.
    Nikolaou, M.
    Farmakis, D.
    Bistola, V.
    Paraskevaidis, I. A.
    Adamopoulos, S.
    Filippatos, G.
    Kremastinos, D. T.
    [J]. HEART, 2008, 94 (05) : 585 - 589
  • [76] Peters Micah D. J., 2017, Medical Reference Services Quarterly, V36, P19, DOI 10.1080/02763869.2017.1259891
  • [77] Systolic versus diastolic heart failure in community practice: Clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors
    Philbin, EF
    Rocco, TA
    Lindenmuth, NW
    Ulrich, K
    Jenkins, PL
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 109 (08) : 605 - 613
  • [78] Pogacar BA., 2017, THESIS MARQUETTE U M
  • [79] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
    Ponikowski, Piotr
    Voors, Adriaan A.
    Anker, Stefan D.
    Bueno, Hector
    Cleland, John G. F.
    Coats, Andrew J. S.
    Falk, Volkmar
    Ramon Gonzalez-Juanatey, Jose
    Harjola, Veli-Pekka
    Jankowska, Ewa A.
    Jessup, Mariell
    Linde, Cecilia
    Nihoyannopoulos, Petros
    Parissis, John T.
    Pieske, Burkert
    Riley, Jillian P.
    Rosano, Giuseppe M. C.
    Ruilope, Luis M.
    Ruschitzka, Frank
    Rutten, Frans H.
    van der Meer, Peter
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (27) : 2129 - U130
  • [80] Heart failure: preventing disease and death worldwide
    Ponikowski, Piotr
    Anker, Stefan D.
    AlHabib, Khalid F.
    Cowie, Martin R.
    Force, Thomas L.
    Hu, Shengshou
    Jaarsma, Tiny
    Krum, Henry
    Rastogi, Vishal
    Rohde, Luis E.
    Samal, Umesh C.
    Shimokawa, Hiroaki
    Siswanto, Bambang Budi
    Sliwa, Karen
    Filippatos, Gerasimos
    [J]. ESC HEART FAILURE, 2014, 1 (01): : 4 - 25